Navigation Links
Soligenix Receives FDA Orphan Drug Designation for RiVax™ for the Prevention of Ricin Intoxication
Date:1/20/2011

PRINCETON, N.J., Jan. 20, 2011 /PRNewswire/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication.  RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.

The US Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders that affect fewer than 200,000 individuals within the United States. In addition to providing a seven-year term of market exclusivity for RiVax™ upon FDA approval, Orphan Drug Designation also positions Soligenix to be able to take advantage of certain financial and regulatory benefits, including government grants for conducting clinical trials, waiver of FDA user fees for the potential submission of a Biologics License Application for RiVax™, and certain tax credits.

RiVax™ induces a protective immune response in animal models of ricin exposure and is currently being evaluated in humans. A human Phase 1A clinical trial of RiVax™ has been completed and a Phase 1B clinical trial remains ongoing. Results of the Phase 1A clinical trial of RiVax™ indicated that the immunogen was safe and induced antibodies anticipated to protect humans from ricin exposure. The outcome of the study was published in the Proceedings of the National Academy of Sciences (Vitetta et al., 2006, PNAS, 105:2268-2273). The Phase 1B trial, sponsored by University of Texas Southwestern Medical Center in Dallas (UT Southwestern), is currently evaluating a more potent formulation of RiVax™. Soligenix has developed processes for la
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
2. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
3. Soligenix to Present at 8th Annual BIO Investor Forum
4. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
5. Soligenix Reports Third Quarter 2009 Financial Results
6. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
7. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
8. Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
9. Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate
10. Soligenix Announces Private Equity Financing of $5.16 Million With Its Partner Sigma-Tau and Other Institutional Investors
11. Soligenix Reports Second Quarter 2010 Financial Results and Reviews Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014  ViveBio, LLC ... sample collection, stabilization and transportation, announced today that ... Procurement Services, LLC (LPS) of Knoxville, ... products in the United States ... class of ambient temperature dried biological specimen transport ...
(Date:8/26/2014)... Francisco, CA (PRWEB) August 26, 2014 ... reach USD 8,020.1 million by 2020, according to a ... for personalized medicine and theranostics, and the subsequent introduction ... key factors driving market growth over the next six ... and chronic diseases such as cancer, coupled with disease ...
(Date:8/26/2014)... Aug. 26, 2014 Trovagene, Inc. (NASDAQ: ... Dx Summit; Moving Assays to the Clinic ... Monitoring of Cell Free Tumor DNA in Urine." ... of its Precision Cancer Monitoring (PCM) platform and ... for the detection of tumor DNA mutations from ...
(Date:8/26/2014)... NEW YORK , Aug. 26, 2014  That,s ... life science markets, today announced the formation of a ... strategic content development. The expanded team will combine current ... messaging areas at That,s Nice. ... Strategic Content to lead the team. Tiene was previously ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... VENTURA, Calif., Dec. 12 VivoMetrics Inc., a ... the,appointment of Howard R. Baker to the position ... Paul Kennedy, who will remain with,the company in ... Baker joins VivoMetrics with over 28 years in ...
... Oral Iclaprim, "Rolling" NDA for Intravenous Iclaprim in cSSSI; Electronic ... First Modules ... Arpida Ltd,(SWX: ARPN) announced today the enrolment and dosing of ... iclaprim in the treatment,of hospital-acquired pneumonia (HAP) / ventilator-associated pneumonia,(VAP) ...
... for the First Time on 50 mg/Day Dose for PRISTIQ ... Treatment of ... a division of Wyeth (NYSE: WYE ), announces that ... serotonin-norepinephrine reuptake inhibitor (SNRI), showed,that adult patients who received a ...
Cached Biology Technology:VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 3First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 4First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6
(Date:8/25/2014)... that there are 133 active fires in the North Slave ... in the past 24 hours. Fire danger is moderate to ... , The Birch Lake Complex of fires are in an ... within 30 km north of Fort Providence. Four crews ... Moraine Point this week. Mop-up continues many areas of complex,s ...
(Date:8/25/2014)... The Happy Camp Complex of fires began as a lightning ... consumed 22,670 acres and is 20% contained. There ... present. It consists of many small fires and a ... have been contained and only account for about 100 acres. ... the morning and early afternoon on August 24, keeping fire ...
(Date:8/25/2014)... August 25, 2014 Nearly 1 in 6 adults ... time, the disorder can cause serious complications. Auriculotherapy, ... points on the outer ear, may help in ... between 2007-2013 that evaluated the effectiveness of auriculotherapy ... discussed in a Review article in The ...
Breaking Biology News(10 mins):Happy Camper and July Fire Complexes in California 2
... ANN ARBOR, Mich. The risk of esophageal cancer ... is not as high as many may think, according ... GERD is considered a relative risk for developing esophageal ... Joel Rubenstein, M.D., M.Sc., an investigator with the Department ...
... -- When their razor-sharp mandibles wear out, leaf-cutter ants ... sisters take over cutting, say researchers from two Oregon ... regular publication in the journal Behavioral Ecology and ... of providing for its displaced workers. "This ...
... can dive for anything up to 15 minutes. However, Bob ... blue whales may be able to dive for longer, because ... blood and muscles, so why don,t they? ,The theory was ... lot of energy, says Shadwick. Explaining that the whales feed ...
Cached Biology News:Esophageal cancer risk lower than expected for patients with GERD 2When their tools get dull, leaf-cutters switch jobs 2When their tools get dull, leaf-cutters switch jobs 3Blue whale-sized mouthfuls make foraging super efficient 2
... The Dodeca silver stain kits are ... devices including Bio-Rad Dodeca stainers. This ... quantities of proteins in polyacrylamide gels ... kit includes sensitizer concentrate, silver reagent ...
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
... stain for staining RNA (bluish-purple), DNA (blue), proteins (red) ... ≥ 90 % Cation traces: Ca ≤ 10 mg/kg ... ≤ 5 mg/kg Cu ≤ 5 mg/kg Fe ≤ ... mg/kg Mn ≤ 5 mg/kg Na ≤ 50 mg/kg ...
... Biometras Tpersonal thermocycler provides maximum performance ... generation of Peltier elements, high heating and ... to short run times. With a maximum ... Tpersonal provides half the capacity of much ...
Biology Products: